Xencor, Inc.
BISPECIFIC ANTIBODIES THAT BIND CD20 AND CD3
Last updated:
Abstract:
The present invention is directed to methods of administrating bispecific anti-CD20.times.anti-CD3 antibodies.
Status:
Application
Type:
Utility
Filling date:
10 Jul 2020
Issue date:
1 Apr 2021